Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of KATP Channel Blockers on GLP-1 and Its Analogues' Mediated Microvascular Function

NCT01934816 is registered in ClinicalTrials.gov with Katarina Kos as lead sponsor.

NCT NCT01934816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01934816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of KATP Channel Blockers on GLP-1 and Its Analogues' Mediated Microvascular Function
Lead sponsor
Katarina Kos
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2013
Completion date
October 31, 2015
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects